The DNA Sequencing Market size is estimated to grow from USD 8.6 Billion in 2022 to reach USD 9.9 Billion by 2030, growing at a CAGR of 14.6% during the forecast period from 2023 to 2030.
Major players DNA Sequencing Market include: Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Illumina, Inc., QIAGEN, F. Hoffmann-La Roche Ltd., Oxford Nanopore Technologies Ltd., Macrogen, Inc., Perkin Elmer, Inc., Pacific Biosciences of California, Inc., BGI, Bio-Rad Laboratories, Inc., Myriad Genetics, PierianDx, Intrexon Bioinformatics Germany GmbH, Eurofins Scientific and Others.
On the other hand, Asia-Pacific market is projected to achieve the highest revenue CAGR. This growth can be attributed to several factors, including the high prevalence of chronic diseases, a rise in healthcare spending, and the continuous improvement of healthcare infrastructure in the region. Moreover, ongoing research on genome sequencing techniques and increasing investments in drug discovery and other research and development activities contribute to the market's expansion. Government and private agencies' increased funding for research activities, along with government initiatives to raise awareness about various types of cancer and cancer treatment options, further stimulate market growth in the Asia-Pacific region. The growing adoption of genetic testing also plays a significant role in driving market expansion. India, China, and Japan are among the key countries contributing to the region's revenue in this market.
The DNA Sequencing Market research report provides an in-depth overview of the industry including market segmentation by Product, Technology, Workflow, Application, End-use and Region. Analysis of the global market with special focus on high growth application in each vertical and fast-growing market segments. It includes detailed competitive landscape with identification of the key players with respect to each type of market, in-depth market share analysis with individual revenue, market shares, and top players rankings. Impact analysis of the market dynamics with factors currently driving and restraining the growth of the market, along with their impact in the short, medium, and long-term landscapes. Competitive intelligence from the company profiles, key player strategies, game-changing developments such as new product launch, collaborations, expansions, investment analysis, mergers and acquisitions.
DNA Sequencing Market is segmented by region and further by countries, Product, Technology, Workflow, Application, End-use and Region. Players, stakeholders, and other participants in the global DNA Sequencing Market will be able to gain a strong position as this report will surely benefit their marketing strategies. The market analysis focuses on revenue and forecast by region/countries and by application in terms of revenue forecast for the period 2023-2030.
Report further studies the market strategies of key players, recent development status, future plans and DNA Sequencing Market trends across the world. Also, it splits DNA Sequencing Market Segmentation by material, end-user and region to deep dive research and reveals company profile and prospects.
This product will be delivered within 3-5 business days.
Major players DNA Sequencing Market include: Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Illumina, Inc., QIAGEN, F. Hoffmann-La Roche Ltd., Oxford Nanopore Technologies Ltd., Macrogen, Inc., Perkin Elmer, Inc., Pacific Biosciences of California, Inc., BGI, Bio-Rad Laboratories, Inc., Myriad Genetics, PierianDx, Intrexon Bioinformatics Germany GmbH, Eurofins Scientific and Others.
The Growth of DNA Sequencing Market Driven by Rising incidence of genetic diseases
The DNA sequencing market is experiencing remarkable growth, fueled by the escalating prevalence of genetic diseases. A surge in conditions like cancer, Alzheimer's disease, and cystic fibrosis has led to a substantial increase in the number of affected individuals, creating a demand for efficient and accurate DNA sequencing methods to aid in diagnosis and treatment. According to the World Health Organization (WHO), approximately 240,000 newborns succumb to congenital disabilities within 28 days of birth each year, with genetic disorders being the primary contributing factor to these fatalities. Consequently, there has been a noticeable uptick in the adoption of DNA sequencing methods and technologies to diagnose and treat genetic disorders. This trend is expected to persist, driving further growth in the DNA sequencing market.Increasing preference for personalized medicine among healthcare providers and patients
The DNA sequencing market is witnessing rapid growth, driven by the increasing preference for personalized medicine among healthcare providers and patients. The adoption of personalized medicine to treat various diseases is on the rise and is expected to continue in the future. Personalized medicine involves tailoring medical procedures to address the specific needs of individual patients, and DNA sequencing plays a significant role in its development. Understanding genetics is crucial in personalized medicine, making DNA sequencing a vital tool in this field. Researchers are using DNA sequencing to identify genetic mutations that contribute to tumor growth and develop targeted therapies for personalized medicine. As personalized medicine becomes a major application of DNA sequencing, the market is experiencing accelerated growth.North America Dominated the DNA Sequencing Market during the forecast period
North America holds a dominant position in the DNA sequencing market, primarily propelled by continuous technological advancements made by key industry players, significant investments in research and development (R&D), and the presence of advanced healthcare infrastructure. Government programs in both the United States and Canada also play a vital role in supporting the development of new cancer treatments and medications. For instance, the BC Cancer Foundation's Personalized Onco-Genomics initiative, operating under the Provincial Health Services Authority in British Columbia, Canada, employs transcriptome and whole-genome analysis to identify cancer genes and corresponding medications. These medications are designed to target crucial pathways in cancer patients, enhancing their effectiveness. Such open-source initiatives are expected to further promote the adoption of these advanced technologies in the region.On the other hand, Asia-Pacific market is projected to achieve the highest revenue CAGR. This growth can be attributed to several factors, including the high prevalence of chronic diseases, a rise in healthcare spending, and the continuous improvement of healthcare infrastructure in the region. Moreover, ongoing research on genome sequencing techniques and increasing investments in drug discovery and other research and development activities contribute to the market's expansion. Government and private agencies' increased funding for research activities, along with government initiatives to raise awareness about various types of cancer and cancer treatment options, further stimulate market growth in the Asia-Pacific region. The growing adoption of genetic testing also plays a significant role in driving market expansion. India, China, and Japan are among the key countries contributing to the region's revenue in this market.
The DNA Sequencing Market research report provides an in-depth overview of the industry including market segmentation by Product, Technology, Workflow, Application, End-use and Region. Analysis of the global market with special focus on high growth application in each vertical and fast-growing market segments. It includes detailed competitive landscape with identification of the key players with respect to each type of market, in-depth market share analysis with individual revenue, market shares, and top players rankings. Impact analysis of the market dynamics with factors currently driving and restraining the growth of the market, along with their impact in the short, medium, and long-term landscapes. Competitive intelligence from the company profiles, key player strategies, game-changing developments such as new product launch, collaborations, expansions, investment analysis, mergers and acquisitions.
DNA Sequencing Market is segmented by region and further by countries, Product, Technology, Workflow, Application, End-use and Region. Players, stakeholders, and other participants in the global DNA Sequencing Market will be able to gain a strong position as this report will surely benefit their marketing strategies. The market analysis focuses on revenue and forecast by region/countries and by application in terms of revenue forecast for the period 2023-2030.
Report further studies the market strategies of key players, recent development status, future plans and DNA Sequencing Market trends across the world. Also, it splits DNA Sequencing Market Segmentation by material, end-user and region to deep dive research and reveals company profile and prospects.
Major Classifications are as follows:
By Product
- Instruments
- Consumables
- Services
By Technology
- Third Generation DNA Sequencing
- Single-Molecule Real-Time Sequencing (SMRT)
- Nanopore Sequencing
- Next-Generation Sequencing
- Whole Genome Sequencing (WGS)
- Whole Exome Sequencing (WES)
- Targeted Sequencing and Resequencing
- Sanger Sequencing
- Others
By Workflow
- Pre-sequencing
- Sequencing
- Data Analysis
By Application
- Clinical Investigation
- Oncology
- Forensics & Agrigenomics
- Reproductive Health
- HLA Typing
- Consumer Genomics
- Others
By End-Use
- Clinical Research
- Academic Research
- Biotechnology & Pharmaceutical Companies
- Hospitals & Clinics
- Others
By Region
- North America
- US
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Rest of Asia Pacific
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
- Rest of Middle East & Africa
Reason to Purchase this DNA Sequencing Market Report:
- Determine prospective investment areas based on a detailed trend analysis of the global DNA Sequencing Market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different and DNA Sequencing Market segments in the top spending countries across the world and identify the opportunities offered by each of them.
- Strengthen your understanding of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels that are driving the global DNA Sequencing Market, providing a clear picture of future opportunities that can be tapped, resulting in revenue expansion.
- Channelize resources by focusing on the ongoing programs that are being undertaken by the different countries within the global DNA Sequencing Market.
- Make correct business decisions based on a thorough analysis of the total competitive landscape of the sector with detailed profiles of the top DNA Sequencing Market providers around the world which include information about their products, alliances, recent contract wins and financial analysis wherever available.
This product will be delivered within 3-5 business days.
Table of Contents
Executive Summary
Key Takeaways
Research Methodology
Market Overview
Market Dynamics
DNA Sequencing Market, By Product
DNA Sequencing Market, By Technology
DNA Sequencing Market, By Workflow
DNA Sequencing Market, By Application
DNA Sequencing Market, By End-Use
DNA Sequencing Market, By Geography
Company Profiles
Companies Mentioned
- Agilent Technologies, Inc.
- Thermo Fisher Scientific, Inc.
- Illumina, Inc.
- QIAGEN
- F. Hoffmann-La Roche Ltd.
- Oxford Nanopore Technologies Ltd.
- Macrogen, Inc.
- Perkin Elmer, Inc.
- Pacific Biosciences of California, Inc.
- BGI
- Bio-Rad Laboratories, Inc.
- Myriad Genetics
- PierianDx
- Intrexon Bioinformatics Germany GmbH
- Eurofins Scientific
